Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICUStudy Protocol Published on 2020-07-082022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] added addition Administered Admission allergy Azithromycin benefit clinical cohort of patient Combination Controlled trial coronavirus disease coronavirus SARS-CoV-2 COVID-19 COVID-19 infection criteria Deterioration disease dose double-blind drug early administration Efficacy febrile disease groups hospital Hydroxychloroquine hypothesise ICU ICU admission in vitro include Infection intensive care intubation limit limitation lung mechanical ventilation mechanically ventilated Mortality not differ novel Novel coronavirus outcome outcomes pathway Patient patients Placebo Pregnancy Prevent prevented progressive COVID-19 Prospective randomised randomised controlled trial RCT receive Respiratory failure SARS-CoV-2 secondary severe COVID-19 Standard of care survival susceptible Symptom Treatment Trial viral replication [DOI] 10.1186/s13063-020-04566-x PMC 바로가기 [Article Type] Study Protocol
Provision of Psychotherapy during the COVID-19 Pandemic among Czech, German and Slovak PsychotherapistsArticle Published on 2020-07-042022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] average Care changed changes in Contact country COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 situation Czech Republic European fear fear of infection female female participants Gender Germany highest infected with COVID-19 investigated less lowest male mental health not differ novel coronavirus disease outbreak participant Patient patients treated provide psychotherapist psychotherapy public health remained remote psychotherapy reported Result Slovakia Spread treated Treatment virus [DOI] 10.3390/ijerph17134811 PMC 바로가기 [Article Type] Article
Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissionsResearch Published on 2020-06-262022-10-29 Journal: International Journal of Stroke [Category] Coronavirus, SARS, [키워드] Acute stroke Admission affected age approaches association Care case sery caused Cerebrovascular disease Characteristics conditions contributing to coronavirus disease Coronavirus disease 2019 courses death disease duration of hospitalization Effect evaluated globe Healthcare system Hospitalization impacted Infection Interaction Iran laboratory-confirmed large vessel life-threatening management Manifestations mortality rate neurologic Neurological disease NEUROLOGY non-infectious not affect not differ objective outbreak outcome pandemic Patient patients plummet Result severity significant changes in significant difference significantly significantly higher stroke Tehran the patient Treatment [DOI] 10.1177/1747493020937397 PMC 바로가기 [Article Type] Research
Taste and Smell Impairment in COVID-19: An AAO-HNS Anosmia Reporting Tool-Based Comparative StudySpecial Section on COVID-19 Published on 2020-06-092022-10-29 Journal: Otolaryngology--Head and Neck Surgery [Category] COVID-19, SARS, [키워드] 95% CI Academy age Ageusia Analysis Anosmia chemosensory Comparative coronavirus coronavirus disease COVID-19 COVID-19 testing described dysgeusia group groups hospital Hypogeusia Hyposmia identify impairment increase indicate Neck not differ objective Odds ratio pandemic polymerase chain regression analysis Reporting responses Result rhinorrhea RT-PCR setting significant difference significantly Smell subject surgery Taste Tertiary the study group was used [DOI] 10.1177/0194599820931820 PMC 바로가기 [Article Type] Special Section on COVID-19
Ultraviolet irradiation doses for coronavirus inactivation – review and analysis of coronavirus photoinactivation studiesArticle Published on 2020-05-142022-11-01 Journal: GMS Hygiene and Infection Control [Category] COVID-19, [키워드] Analysis Antiviral effect appear available data caused condition coronavirus COVID-19 determine Disinfection dose evaluated excluded experiment inactivation irradiation limit median MERS-CoV Modification Mutation new SARS-CoV-2 not differ performed Radiation dose reduction required reveal RNA SARS-CoV SARS-CoV-2 selected Spread the SARS-CoV-2 virus ultraviolet ultraviolet irradiation ultraviolet light Ultraviolet radiation UVC variations virus [DOI] 10.3205/dgkh000343 PMC 바로가기 [Article Type] Article
The missing acute coronary syndromes in the COVID-19 eraObservational Study Published on 2020-01-012022-10-05 Journal: Therapeutic advances in cardiovascular disease [Category] 임상, [키워드] Acute coronary syndrome average collected COVID-19 COVID-19 pandemic determine entire spectrum hospital London measure media Myocardial infarction not differ NSTEMI number observé Patient Percutaneous coronary intervention presenting promoted reduced reduction in remained self-quarantine significantly social distancing Social distancing measure STEMI Treatment United Kingdom [DOI] 10.1177/1753944720977732 PMC 바로가기 [Article Type] Observational Study
The immune response of young turkeys to haemorrhagic enteritis virus infection at different levels and sources of methionine in the dietResearch Article Published on 2019-11-012022-10-28 Journal: BMC veterinary research [Category] Coronavirus, [키워드] added addition Administered age Amino acid analysed appear assigned B cell Blood CD25 CD4 CD8 Cell cell subpopulation decrease described diagnosed disease dose evaluate Haemorrhagic enteritis virus Humoral immunity hydroxy IgA levels IgM IL-6 IL-6 level immune function immune response impair increase in Infection interleukin-6 isolate metabolic pathway methionine moderate not differ parameter parameters pathogenic percentage plasma Poland positive receiving regulate Result secondary bacterial infection severe immunosuppression significant decrease significantly spleen strain tonsil Treatment Turkey Turkeys uninfected USA virus virus infection [DOI] 10.1186/s12917-019-2138-8 PMC 바로가기 [Article Type] Research Article
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study인간 면역 결핍 바이러스의 위험이 있는 젊은이들 사이에서 노출 전 예방에 대한 유지 및 준수를 촉진하기 위한 모바일 건강 중재의 무작위 대조 시험: EPIC 연구Articles and Commentaries Published on 2019-06-152022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] 95% CI 95% confidence interval acquisition adherence age bidirectional Blood clinical Concentration conducted Controlled demonstrated doses drug levels Effectiveness Efficacy enrolled EpiC evaluate evaluated HIV Human Human immunodeficiency virus immunodeficiency virus individual Infection insurance Intervention Latino Logistic men men who have sex with men (MSM) Mobile not differ Odds ratio outcome participant preexposure prophylaxis preexposure prophylaxis (PrEP) PrEP Prophylaxis Randomized Randomized controlled trial receive Registration reported Result retention risk robust Sex significantly significantly increased SOC Standard of care study visit tenofovir tenofovir diphosphate text-messaging TFV-DP Youth [DOI] 10.1093/cid/ciy810 PMC 바로가기 [Article Type] Articles and Commentaries
Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infectionsResearch Article Published on 2017-01-142022-10-28 Journal: BMC Infectious Diseases [Category] Coronavirus, MERS, [키워드] age antimicrobial agent Antiviral ARMS Barrier formation cetylpyridinium chloride clinical trial Comparisons component conducted Contact coronavirus cough current demonstrated double-blind double-blinded Effectiveness Efficacy enrolled evaluate Frequency Glycerin had no Host individual Influenza Invasion medication mucosa not differ not significant occurred outcome pilot clinical trial placebo group placebo-controlled placebo-controlled clinical trial proof-of-concept clinical trial Prophylaxis Randomized reduced reducing reduction Registered reported representing Result rhinovirus Safe Secondary objective severity significantly sore throat statistically study outcomes study participant Study participants subject supplementary material the placebo group Tolerability treatment of influenza upper respiratory infection vaccination virus detection was reduced Xanthan gum [DOI] 10.1186/s12879-016-2177-8 PMC 바로가기 [Article Type] Research Article
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patientsHIV 양성 환자에서 로수바스타틴 적정 단독요법과 비교한 에제티미브와 로수바스타틴 병용요법의 지질강하 효능 및 안전성Research Published on 2015-06-192022-09-06 Journal: Lipids in Health and Disease [Category] Communicable Disease, [키워드] addition AIP ALT Antiretroviral therapy API apoA1 ApoB Apolipoprotein B appear AST baseline characteristics C-reactive protein change Characteristics cholesterol clinical symptom Clinical symptoms clinical trial Combination combination treatment develop dose dyslipidemia dyslipidemias Efficacy Efficacy and safety eligible examined Ezetimibe group groups guideline HDL-C High-density lipoprotein High-density lipoprotein cholesterol High-sensitivity C-reactive protein HIV HIV-infected patient HIV-infected patients hsCRP improvement increase in LDL-C Lipid lipid profile Low-density lipoprotein Low-Density Lipoprotein cholesterol Mild minimum monotherapy myalgias not differ Open-label parameter Patient patients with HIV percentage plasma Primary outcome Randomized Result Rosuvastatin Safe Significant statin targets therapy Total cholesterol Transport treatment groups Trial Triglyceride two patients [DOI] 10.1186/s12944-015-0054-x PMC 바로가기 [Article Type] Research